Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 9.47282668 |
2 | polyketide metabolic process (GO:0030638) | 9.47282668 |
3 | doxorubicin metabolic process (GO:0044598) | 9.47282668 |
4 | interferon-gamma production (GO:0032609) | 6.40153511 |
5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.78195862 |
6 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.58048808 |
7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.48672295 |
8 | maintenance of protein location in nucleus (GO:0051457) | 5.39250471 |
9 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.03423652 |
10 | somite rostral/caudal axis specification (GO:0032525) | 4.93715957 |
11 | protein localization to kinetochore (GO:0034501) | 4.83001401 |
12 | negative regulation of epidermis development (GO:0045683) | 4.54614541 |
13 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.49232155 |
14 | histone H4-K12 acetylation (GO:0043983) | 4.45679617 |
15 | negative regulation of telomere maintenance (GO:0032205) | 4.30283215 |
16 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.21650680 |
17 | rRNA transcription (GO:0009303) | 4.21129014 |
18 | muscle organ morphogenesis (GO:0048644) | 4.19918099 |
19 | rRNA methylation (GO:0031167) | 4.15476038 |
20 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.15373869 |
21 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.15373869 |
22 | regulation of cilium movement (GO:0003352) | 3.97821793 |
23 | regulation of response to osmotic stress (GO:0047484) | 3.93346782 |
24 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.89443414 |
25 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.86783031 |
26 | rRNA modification (GO:0000154) | 3.85799505 |
27 | histone H4-K5 acetylation (GO:0043981) | 3.84287219 |
28 | histone H4-K8 acetylation (GO:0043982) | 3.84287219 |
29 | positive regulation of defense response to virus by host (GO:0002230) | 3.81879362 |
30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.81629531 |
31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77441512 |
32 | piRNA metabolic process (GO:0034587) | 3.68236874 |
33 | DNA deamination (GO:0045006) | 3.63988396 |
34 | DNA replication checkpoint (GO:0000076) | 3.63157113 |
35 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61221279 |
36 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.58181091 |
37 | negative regulation of telomerase activity (GO:0051974) | 3.55764230 |
38 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.53757923 |
39 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.45773305 |
40 | centriole replication (GO:0007099) | 3.45231035 |
41 | tolerance induction (GO:0002507) | 3.42693541 |
42 | regulation of telomere maintenance (GO:0032204) | 3.42217426 |
43 | cell wall macromolecule catabolic process (GO:0016998) | 3.42090323 |
44 | mitotic sister chromatid segregation (GO:0000070) | 3.40984741 |
45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39190654 |
46 | protein K11-linked deubiquitination (GO:0035871) | 3.33856431 |
47 | phenol-containing compound catabolic process (GO:0019336) | 3.28696604 |
48 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.23376978 |
49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19163352 |
50 | cytidine metabolic process (GO:0046087) | 3.14224060 |
51 | cytidine catabolic process (GO:0006216) | 3.14224060 |
52 | cytidine deamination (GO:0009972) | 3.14224060 |
53 | regulation of T-helper cell differentiation (GO:0045622) | 3.14160254 |
54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12840797 |
55 | cell wall macromolecule metabolic process (GO:0044036) | 3.11935668 |
56 | multicellular organism reproduction (GO:0032504) | 3.10466265 |
57 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.08744677 |
58 | response to dietary excess (GO:0002021) | 3.08455908 |
59 | RNA destabilization (GO:0050779) | 3.08089524 |
60 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07500718 |
61 | response to peptidoglycan (GO:0032494) | 3.06594595 |
62 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.04702171 |
63 | nuclear pore complex assembly (GO:0051292) | 3.04317010 |
64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.04296875 |
65 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.04114762 |
66 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.03778971 |
67 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.02797330 |
68 | notochord development (GO:0030903) | 3.01872509 |
69 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.01671528 |
70 | nucleoside transmembrane transport (GO:1901642) | 3.00730147 |
71 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00619172 |
72 | negative regulation of bone resorption (GO:0045779) | 2.98165476 |
73 | neutrophil activation (GO:0042119) | 2.97708110 |
74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96521421 |
75 | DNA damage response, detection of DNA damage (GO:0042769) | 2.94304363 |
76 | pseudouridine synthesis (GO:0001522) | 2.94078775 |
77 | neutrophil activation involved in immune response (GO:0002283) | 2.93212842 |
78 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91671808 |
79 | negative regulation of interleukin-12 production (GO:0032695) | 2.90460252 |
80 | quinone metabolic process (GO:1901661) | 2.89439597 |
81 | primitive streak formation (GO:0090009) | 2.88718845 |
82 | negative regulation of interleukin-2 production (GO:0032703) | 2.88310964 |
83 | response to muramyl dipeptide (GO:0032495) | 2.88305469 |
84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87226945 |
85 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.85433359 |
86 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.84029413 |
87 | positive regulation of developmental pigmentation (GO:0048087) | 2.83870404 |
88 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.83711914 |
89 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.83711914 |
90 | pore complex assembly (GO:0046931) | 2.83688630 |
91 | histone H4-K16 acetylation (GO:0043984) | 2.83313141 |
92 | DNA methylation involved in gamete generation (GO:0043046) | 2.82671231 |
93 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.82377133 |
94 | histone H3-K4 trimethylation (GO:0080182) | 2.80490652 |
95 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80276845 |
96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.79597703 |
97 | L-fucose catabolic process (GO:0042355) | 2.79225964 |
98 | fucose catabolic process (GO:0019317) | 2.79225964 |
99 | L-fucose metabolic process (GO:0042354) | 2.79225964 |
100 | negative regulation of cell killing (GO:0031342) | 2.78703424 |
101 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.78703424 |
102 | regulation of translation in response to stress (GO:0043555) | 2.78161352 |
103 | chromatin assembly (GO:0031497) | 2.77983167 |
104 | regulation of germinal center formation (GO:0002634) | 2.77568337 |
105 | positive regulation of interleukin-17 production (GO:0032740) | 2.75543243 |
106 | sister chromatid segregation (GO:0000819) | 2.75351562 |
107 | positive regulation of odontogenesis (GO:0042482) | 2.75091209 |
108 | dendritic cell chemotaxis (GO:0002407) | 2.72658996 |
109 | negative regulation of interleukin-1 production (GO:0032692) | 2.72138958 |
110 | cellular extravasation (GO:0045123) | 2.71692136 |
111 | defense response to protozoan (GO:0042832) | 2.71362258 |
112 | bone trabecula formation (GO:0060346) | 2.69410327 |
113 | mast cell activation (GO:0045576) | 2.68514020 |
114 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.68136512 |
115 | regulation of T-helper 1 type immune response (GO:0002825) | 2.67688381 |
116 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.67354202 |
117 | neutrophil mediated immunity (GO:0002446) | 2.66228409 |
118 | cullin deneddylation (GO:0010388) | 2.66135428 |
119 | dendritic cell migration (GO:0036336) | 2.65633182 |
120 | positive regulation of tissue remodeling (GO:0034105) | 2.64383109 |
121 | response to protozoan (GO:0001562) | 2.62896555 |
122 | cellular response to interleukin-15 (GO:0071350) | 2.60437534 |
123 | granulocyte activation (GO:0036230) | 2.59757693 |
124 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59614969 |
125 | T-helper cell differentiation (GO:0042093) | 2.58586809 |
126 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.58586809 |
127 | ribosome biogenesis (GO:0042254) | 2.57935921 |
128 | T cell differentiation involved in immune response (GO:0002292) | 2.56196544 |
129 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.56196544 |
130 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.56196544 |
131 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.55415929 |
132 | regulation of defense response to virus by host (GO:0050691) | 2.54694418 |
133 | positive regulation of interferon-beta production (GO:0032728) | 2.54630293 |
134 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.54405856 |
135 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53844151 |
136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.53660844 |
137 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.52886527 |
138 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.52628122 |
139 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.52582069 |
140 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.52238023 |
141 | positive regulation of protein deacetylation (GO:0090312) | 2.51687413 |
142 | nuclear pore organization (GO:0006999) | 2.51449625 |
143 | male meiosis (GO:0007140) | 2.50533206 |
144 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.49589957 |
145 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.49148904 |
146 | regulation of gene silencing by RNA (GO:0060966) | 2.49128810 |
147 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.49128810 |
148 | regulation of gene silencing by miRNA (GO:0060964) | 2.49128810 |
149 | negative thymic T cell selection (GO:0045060) | 2.48955075 |
150 | histone H3-K4 methylation (GO:0051568) | 2.48056605 |
151 | protein deneddylation (GO:0000338) | 2.48011280 |
152 | protein polyglutamylation (GO:0018095) | 2.47962496 |
153 | immunoglobulin mediated immune response (GO:0016064) | 2.47652591 |
154 | mitotic G2/M transition checkpoint (GO:0044818) | 2.47613609 |
155 | regulation of alpha-beta T cell activation (GO:0046634) | 2.46292560 |
156 | negative T cell selection (GO:0043383) | 2.45352502 |
157 | platelet dense granule organization (GO:0060155) | 2.44837958 |
158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44499375 |
159 | negative regulation of bone remodeling (GO:0046851) | 2.44437497 |
160 | microtubule severing (GO:0051013) | 2.44411060 |
161 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.42543147 |
162 | leukocyte aggregation (GO:0070486) | 2.42469231 |
163 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.41644912 |
164 | mast cell activation involved in immune response (GO:0002279) | 2.41373974 |
165 | mast cell degranulation (GO:0043303) | 2.41373974 |
166 | response to interleukin-15 (GO:0070672) | 2.41310148 |
167 | regulation of telomerase activity (GO:0051972) | 2.40725061 |
168 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.39883081 |
169 | negative regulation of viral release from host cell (GO:1902187) | 2.38997954 |
170 | leukocyte degranulation (GO:0043299) | 2.38601851 |
171 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.38469601 |
172 | natural killer cell activation involved in immune response (GO:0002323) | 2.38243000 |
173 | Rap protein signal transduction (GO:0032486) | 2.37798810 |
174 | ventricular system development (GO:0021591) | 2.37598754 |
175 | sperm motility (GO:0030317) | 2.36459944 |
176 | maintenance of protein localization in organelle (GO:0072595) | 2.35322035 |
177 | heterochromatin organization (GO:0070828) | 2.35187747 |
178 | establishment of endothelial barrier (GO:0061028) | 2.34366879 |
179 | negative regulation of T cell differentiation (GO:0045581) | 2.34141882 |
180 | histone mRNA catabolic process (GO:0071044) | 2.34038192 |
181 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.34002944 |
182 | B cell mediated immunity (GO:0019724) | 2.33835143 |
183 | T cell migration (GO:0072678) | 2.33594306 |
184 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.33390060 |
185 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.32971798 |
186 | regulation of interferon-beta production (GO:0032648) | 2.32390193 |
187 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.31649480 |
188 | regulation of female gonad development (GO:2000194) | 2.31646116 |
189 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.28753231 |
190 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.28753231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.59229259 |
2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.39438372 |
3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.39438372 |
4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.39438372 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.90512889 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.66828936 |
7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 4.58218014 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68607933 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86637962 |
10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.73933753 |
11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.71285143 |
12 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.69831808 |
13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69421126 |
14 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.54892262 |
15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.46271585 |
16 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.44194226 |
17 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.26455927 |
18 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.04998652 |
19 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.98003601 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94342448 |
21 | GATA3_26560356_Chip-Seq_TH2_Human | 1.88061775 |
22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.87979933 |
23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84220763 |
24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83753682 |
25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.81870991 |
26 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.79833272 |
27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78719711 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76799890 |
29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76006678 |
30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.75570562 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73690430 |
32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72335060 |
33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71563902 |
34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69219842 |
35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.62363393 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62062801 |
37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56013317 |
38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52174391 |
39 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.51196302 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49646278 |
41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49264766 |
42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47897667 |
43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46228670 |
44 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.45995738 |
45 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45484605 |
46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45293974 |
47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45158707 |
48 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.43369902 |
49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41565056 |
50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40907024 |
51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40635766 |
52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36560832 |
53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36198526 |
54 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.34582798 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32804834 |
56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.32108486 |
57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31566408 |
58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31063756 |
59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30481700 |
60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25497505 |
61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23974233 |
62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23966999 |
63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23518643 |
64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22636121 |
65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20721701 |
66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20698533 |
67 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19667320 |
68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18502824 |
69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.17465727 |
70 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.16721623 |
71 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15993829 |
72 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.15211716 |
73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15062766 |
74 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.14954868 |
75 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14898519 |
76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14280739 |
77 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14235353 |
78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13804464 |
79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12896914 |
80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12802565 |
81 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11590478 |
82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11223220 |
83 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11169459 |
84 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.11056823 |
85 | GATA3_26560356_Chip-Seq_TH1_Human | 1.10913267 |
86 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09702377 |
87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09199237 |
88 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09161803 |
89 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08628466 |
90 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.08198247 |
91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07516662 |
92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06934632 |
93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06608623 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06352554 |
95 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.06329521 |
96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06276933 |
97 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05439441 |
98 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05419947 |
99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05313275 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05159885 |
101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03419696 |
102 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.02561970 |
103 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02302972 |
104 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02146578 |
105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01449564 |
106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01449564 |
107 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01390787 |
108 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.01222835 |
109 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01038415 |
110 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00828521 |
111 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00240566 |
112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99840539 |
113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99686750 |
114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98896121 |
115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98639127 |
116 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98349003 |
117 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.98332594 |
118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98120654 |
119 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.96961087 |
120 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96931882 |
121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96686793 |
122 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.96272357 |
123 | MYB_26560356_Chip-Seq_TH1_Human | 0.96142026 |
124 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95437494 |
125 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.95021467 |
126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94925215 |
127 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.94331408 |
128 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.94269912 |
129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93995037 |
130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93617552 |
131 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92813462 |
132 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92608436 |
133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92535843 |
134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92535843 |
135 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92239175 |
136 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89369334 |
137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88622901 |
138 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86130110 |
139 | MYB_26560356_Chip-Seq_TH2_Human | 0.85485451 |
140 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.85322221 |
141 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85183386 |
142 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85073576 |
143 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.84557602 |
144 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.82638269 |
145 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.81998378 |
146 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81824952 |
147 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.80806110 |
148 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.79792591 |
149 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79768668 |
150 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.77873896 |
151 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.77229981 |
152 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.77189390 |
153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77048684 |
154 | * TTF2_22483619_ChIP-Seq_HELA_Human | 0.76072237 |
155 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75260970 |
156 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.73958852 |
157 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71534240 |
158 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70738622 |
159 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.70308429 |
160 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70012198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0006292_abnormal_olfactory_placode | 4.54667212 |
2 | MP0008057_abnormal_DNA_replication | 4.16573840 |
3 | MP0005075_abnormal_melanosome_morpholog | 4.13784915 |
4 | MP0003724_increased_susceptibility_to | 4.13632299 |
5 | MP0003011_delayed_dark_adaptation | 3.09466742 |
6 | MP0004264_abnormal_extraembryonic_tissu | 3.08204661 |
7 | MP0002277_abnormal_respiratory_mucosa | 2.96764517 |
8 | MP0008877_abnormal_DNA_methylation | 2.53139685 |
9 | MP0003122_maternal_imprinting | 2.51828762 |
10 | MP0004381_abnormal_hair_follicle | 2.46579888 |
11 | MP0003890_abnormal_embryonic-extraembry | 2.43404403 |
12 | MP0003183_abnormal_peptide_metabolism | 2.39867410 |
13 | MP0005394_taste/olfaction_phenotype | 2.35142137 |
14 | MP0005499_abnormal_olfactory_system | 2.35142137 |
15 | MP0002254_reproductive_system_inflammat | 2.34821276 |
16 | MP0003136_yellow_coat_color | 2.32382420 |
17 | MP0003121_genomic_imprinting | 2.26300442 |
18 | MP0004957_abnormal_blastocyst_morpholog | 2.21664139 |
19 | MP0002419_abnormal_innate_immunity | 2.15851625 |
20 | MP0006082_CNS_inflammation | 2.09187433 |
21 | MP0008995_early_reproductive_senescence | 2.05509768 |
22 | MP0003195_calcinosis | 2.03233647 |
23 | MP0005410_abnormal_fertilization | 1.96681807 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.90877811 |
25 | MP0005084_abnormal_gallbladder_morpholo | 1.89120257 |
26 | MP0002332_abnormal_exercise_endurance | 1.85560483 |
27 | MP0004858_abnormal_nervous_system | 1.83124539 |
28 | MP0003718_maternal_effect | 1.82589580 |
29 | MP0003787_abnormal_imprinting | 1.82145598 |
30 | MP0001853_heart_inflammation | 1.81209634 |
31 | MP0003938_abnormal_ear_development | 1.77766979 |
32 | MP0005671_abnormal_response_to | 1.72107539 |
33 | MP0009764_decreased_sensitivity_to | 1.68552631 |
34 | MP0000569_abnormal_digit_pigmentation | 1.61404313 |
35 | MP0002396_abnormal_hematopoietic_system | 1.55342532 |
36 | MP0005000_abnormal_immune_tolerance | 1.53227915 |
37 | MP0005257_abnormal_intraocular_pressure | 1.52070218 |
38 | MP0008961_abnormal_basal_metabolism | 1.52008532 |
39 | MP0001845_abnormal_inflammatory_respons | 1.44179138 |
40 | MP0003303_peritoneal_inflammation | 1.44048971 |
41 | MP0003077_abnormal_cell_cycle | 1.37815394 |
42 | MP0003866_abnormal_defecation | 1.35322345 |
43 | MP0001800_abnormal_humoral_immune | 1.33233660 |
44 | MP0001501_abnormal_sleep_pattern | 1.28756427 |
45 | MP0000049_abnormal_middle_ear | 1.28405642 |
46 | MP0009785_altered_susceptibility_to | 1.26043457 |
47 | MP0005387_immune_system_phenotype | 1.25941665 |
48 | MP0001790_abnormal_immune_system | 1.25941665 |
49 | MP0005310_abnormal_salivary_gland | 1.25802063 |
50 | MP0000490_abnormal_crypts_of | 1.25030702 |
51 | MP0001835_abnormal_antigen_presentation | 1.23830363 |
52 | MP0003763_abnormal_thymus_physiology | 1.23798216 |
53 | MP0001293_anophthalmia | 1.23734756 |
54 | MP0001533_abnormal_skeleton_physiology | 1.22827521 |
55 | MP0010094_abnormal_chromosome_stability | 1.22139643 |
56 | MP0000762_abnormal_tongue_morphology | 1.21781228 |
57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21460144 |
58 | MP0001672_abnormal_embryogenesis/_devel | 1.20623861 |
59 | MP0005380_embryogenesis_phenotype | 1.20623861 |
60 | MP0006072_abnormal_retinal_apoptosis | 1.20447674 |
61 | MP0002751_abnormal_autonomic_nervous | 1.20361709 |
62 | MP0002928_abnormal_bile_duct | 1.20171871 |
63 | MP0008469_abnormal_protein_level | 1.20134458 |
64 | MP0000372_irregular_coat_pigmentation | 1.19950962 |
65 | MP0008789_abnormal_olfactory_epithelium | 1.18597916 |
66 | MP0008932_abnormal_embryonic_tissue | 1.18269203 |
67 | MP0002653_abnormal_ependyma_morphology | 1.18164250 |
68 | MP0008007_abnormal_cellular_replicative | 1.18010669 |
69 | MP0002098_abnormal_vibrissa_morphology | 1.17172075 |
70 | MP0002405_respiratory_system_inflammati | 1.16847118 |
71 | MP0003646_muscle_fatigue | 1.14891901 |
72 | MP0002723_abnormal_immune_serum | 1.14085479 |
73 | MP0001986_abnormal_taste_sensitivity | 1.13683786 |
74 | MP0001929_abnormal_gametogenesis | 1.13181728 |
75 | MP0003806_abnormal_nucleotide_metabolis | 1.13003741 |
76 | MP0000350_abnormal_cell_proliferation | 1.12245206 |
77 | MP0003111_abnormal_nucleus_morphology | 1.11615471 |
78 | MP0003786_premature_aging | 1.11205063 |
79 | MP0006035_abnormal_mitochondrial_morpho | 1.11087201 |
80 | MP0003315_abnormal_perineum_morphology | 1.10293926 |
81 | MP0002163_abnormal_gland_morphology | 1.09692011 |
82 | MP0003252_abnormal_bile_duct | 1.07049986 |
83 | MP0002088_abnormal_embryonic_growth/wei | 1.06996116 |
84 | MP0001819_abnormal_immune_cell | 1.06549302 |
85 | MP0003984_embryonic_growth_retardation | 1.05829038 |
86 | MP0004947_skin_inflammation | 1.05026816 |
87 | MP0002420_abnormal_adaptive_immunity | 1.05006686 |
88 | MP0002398_abnormal_bone_marrow | 1.04275228 |
89 | MP0000689_abnormal_spleen_morphology | 1.04152523 |
90 | MP0003755_abnormal_palate_morphology | 1.03900090 |
91 | MP0002452_abnormal_antigen_presenting | 1.03854807 |
92 | MP0003436_decreased_susceptibility_to | 1.03418713 |
93 | MP0001873_stomach_inflammation | 1.03142432 |
94 | MP0002722_abnormal_immune_system | 1.01830102 |
95 | MP0002127_abnormal_cardiovascular_syste | 1.01661367 |
96 | MP0000432_abnormal_head_morphology | 1.01170117 |
97 | MP0008058_abnormal_DNA_repair | 1.00857045 |
98 | MP0010155_abnormal_intestine_physiology | 1.00359882 |
99 | MP0005025_abnormal_response_to | 1.00179660 |
100 | MP0002092_abnormal_eye_morphology | 0.99791951 |
101 | MP0000678_abnormal_parathyroid_gland | 0.99066165 |
102 | MP0000716_abnormal_immune_system | 0.98776648 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 0.98161192 |
104 | MP0000703_abnormal_thymus_morphology | 0.97106072 |
105 | MP0002132_abnormal_respiratory_system | 0.96786927 |
106 | MP0002148_abnormal_hypersensitivity_rea | 0.96428325 |
107 | MP0009278_abnormal_bone_marrow | 0.93951465 |
108 | MP0002102_abnormal_ear_morphology | 0.91632068 |
109 | MP0001764_abnormal_homeostasis | 0.91262674 |
110 | MP0005646_abnormal_pituitary_gland | 0.90829301 |
111 | MP0002932_abnormal_joint_morphology | 0.90544083 |
112 | MP0003943_abnormal_hepatobiliary_system | 0.89730531 |
113 | MP0002429_abnormal_blood_cell | 0.89096984 |
114 | MP0001545_abnormal_hematopoietic_system | 0.88988333 |
115 | MP0005397_hematopoietic_system_phenotyp | 0.88988333 |
116 | MP0000685_abnormal_immune_system | 0.88024181 |
117 | MP0009333_abnormal_splenocyte_physiolog | 0.87491008 |
118 | MP0003693_abnormal_embryo_hatching | 0.87242193 |
119 | MP0002114_abnormal_axial_skeleton | 0.86399721 |
120 | MP0000015_abnormal_ear_pigmentation | 0.86175595 |
121 | MP0005464_abnormal_platelet_physiology | 0.84076511 |
122 | MP0003448_altered_tumor_morphology | 0.83771421 |
123 | MP0005379_endocrine/exocrine_gland_phen | 0.83195174 |
124 | MP0004133_heterotaxia | 0.82612147 |
125 | MP0000313_abnormal_cell_death | 0.81597638 |
126 | MP0002006_tumorigenesis | 0.80900348 |
127 | MP0002233_abnormal_nose_morphology | 0.80670917 |
128 | MP0005551_abnormal_eye_electrophysiolog | 0.80591660 |
129 | MP0003698_abnormal_male_reproductive | 0.80493712 |
130 | MP0005391_vision/eye_phenotype | 0.80179948 |
131 | MP0002166_altered_tumor_susceptibility | 0.80154430 |
132 | MP0002085_abnormal_embryonic_tissue | 0.80014793 |
133 | MP0001849_ear_inflammation | 0.78632233 |
134 | MP0003937_abnormal_limbs/digits/tail_de | 0.77096896 |
135 | MP0002210_abnormal_sex_determination | 0.76997627 |
136 | MP0004883_abnormal_blood_vessel | 0.76405430 |
137 | MP0002116_abnormal_craniofacial_bone | 0.76217723 |
138 | MP0001188_hyperpigmentation | 0.75410637 |
139 | MP0002095_abnormal_skin_pigmentation | 0.74316588 |
140 | MP0008872_abnormal_physiological_respon | 0.73864670 |
141 | MP0001919_abnormal_reproductive_system | 0.73493824 |
142 | MP0005164_abnormal_response_to | 0.71750691 |
143 | MP0010352_gastrointestinal_tract_polyps | 0.71146777 |
144 | MP0006036_abnormal_mitochondrial_physio | 0.70714532 |
145 | MP0003828_pulmonary_edema | 0.70448750 |
146 | MP0002876_abnormal_thyroid_physiology | 0.70376937 |
147 | MP0002086_abnormal_extraembryonic_tissu | 0.70250931 |
148 | MP0000653_abnormal_sex_gland | 0.70065904 |
149 | MP0001348_abnormal_lacrimal_gland | 0.69722020 |
150 | MP0005395_other_phenotype | 0.68977401 |
151 | MP0009765_abnormal_xenobiotic_induced | 0.68818950 |
152 | MP0009763_increased_sensitivity_to | 0.68059989 |
153 | MP0010030_abnormal_orbit_morphology | 0.67707115 |
154 | MP0005174_abnormal_tail_pigmentation | 0.66096868 |
155 | MP0004197_abnormal_fetal_growth/weight/ | 0.64564713 |
156 | MP0002019_abnormal_tumor_incidence | 0.64378833 |
157 | MP0005248_abnormal_Harderian_gland | 0.63339909 |
158 | MP0001286_abnormal_eye_development | 0.62692914 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 5.42795019 |
2 | Hypochromic microcytic anemia (HP:0004840) | 4.82864607 |
3 | Rib fusion (HP:0000902) | 4.48315700 |
4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.31790367 |
5 | Rectovaginal fistula (HP:0000143) | 3.84147046 |
6 | Rectal fistula (HP:0100590) | 3.84147046 |
7 | Chromsome breakage (HP:0040012) | 3.83285711 |
8 | Stomach cancer (HP:0012126) | 3.63020615 |
9 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.62192747 |
10 | Hypoplasia of the fovea (HP:0007750) | 3.62084324 |
11 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.62084324 |
12 | Intestinal fistula (HP:0100819) | 3.44448029 |
13 | Embryonal renal neoplasm (HP:0011794) | 3.41098034 |
14 | Anomalous pulmonary venous return (HP:0010772) | 3.28469214 |
15 | Fused cervical vertebrae (HP:0002949) | 3.20554226 |
16 | Testicular atrophy (HP:0000029) | 3.17697528 |
17 | Vaginal fistula (HP:0004320) | 3.13976493 |
18 | Ependymoma (HP:0002888) | 3.11252997 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.09426495 |
20 | Hepatoblastoma (HP:0002884) | 3.06522236 |
21 | Eczematoid dermatitis (HP:0000976) | 3.04908485 |
22 | Pancreatic cysts (HP:0001737) | 3.04472876 |
23 | Molar tooth sign on MRI (HP:0002419) | 3.04068393 |
24 | Abnormality of midbrain morphology (HP:0002418) | 3.04068393 |
25 | Abnormality of the pulmonary veins (HP:0011718) | 2.99449400 |
26 | Abnormality of T cell physiology (HP:0011840) | 2.96891170 |
27 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.95943307 |
28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.94714605 |
29 | Recurrent bacterial skin infections (HP:0005406) | 2.90158075 |
30 | Partial duplication of thumb phalanx (HP:0009944) | 2.85969718 |
31 | Recurrent fungal infections (HP:0002841) | 2.83715673 |
32 | Nasolacrimal duct obstruction (HP:0000579) | 2.83455653 |
33 | Recurrent abscess formation (HP:0002722) | 2.82042768 |
34 | IgG deficiency (HP:0004315) | 2.77813283 |
35 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76804921 |
36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76804921 |
37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76804921 |
38 | Neoplasm of striated muscle (HP:0009728) | 2.76361703 |
39 | Abnormality of the fovea (HP:0000493) | 2.74992662 |
40 | Sensory axonal neuropathy (HP:0003390) | 2.68432615 |
41 | Pancreatic fibrosis (HP:0100732) | 2.68342168 |
42 | Rhabdomyosarcoma (HP:0002859) | 2.66643969 |
43 | Severe visual impairment (HP:0001141) | 2.64905071 |
44 | Meckel diverticulum (HP:0002245) | 2.64384569 |
45 | Abnormality of T cells (HP:0002843) | 2.63589703 |
46 | Abnormality of the ileum (HP:0001549) | 2.61955840 |
47 | Orchitis (HP:0100796) | 2.58871947 |
48 | Chronic sinusitis (HP:0011109) | 2.56432392 |
49 | Panhypogammaglobulinemia (HP:0003139) | 2.55661287 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.47354261 |
51 | Abnormal lung lobation (HP:0002101) | 2.46462982 |
52 | Multiple enchondromatosis (HP:0005701) | 2.46255385 |
53 | Bifid tongue (HP:0010297) | 2.46165967 |
54 | Combined immunodeficiency (HP:0005387) | 2.46048962 |
55 | Nephronophthisis (HP:0000090) | 2.44648390 |
56 | Prostate neoplasm (HP:0100787) | 2.44212281 |
57 | Mediastinal lymphadenopathy (HP:0100721) | 2.43508323 |
58 | Partial duplication of the phalanx of hand (HP:0009999) | 2.42567470 |
59 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.42362606 |
60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.42342570 |
61 | Oligodactyly (hands) (HP:0001180) | 2.41955945 |
62 | Supernumerary spleens (HP:0009799) | 2.41931335 |
63 | Azoospermia (HP:0000027) | 2.40945273 |
64 | Abnormal spermatogenesis (HP:0008669) | 2.40224412 |
65 | True hermaphroditism (HP:0010459) | 2.35591750 |
66 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33161200 |
67 | Recurrent bronchitis (HP:0002837) | 2.32176012 |
68 | Reduced antithrombin III activity (HP:0001976) | 2.31867391 |
69 | Keratoconjunctivitis (HP:0001096) | 2.31501917 |
70 | Encephalitis (HP:0002383) | 2.31476162 |
71 | IgM deficiency (HP:0002850) | 2.31133312 |
72 | Abnormality of macrophages (HP:0004311) | 2.29115943 |
73 | Abnormality of B cell number (HP:0010975) | 2.28851388 |
74 | Abnormality of the lower motor neuron (HP:0002366) | 2.28536474 |
75 | Meningitis (HP:0001287) | 2.27603750 |
76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27243047 |
77 | Impulsivity (HP:0100710) | 2.27101527 |
78 | Keratoconjunctivitis sicca (HP:0001097) | 2.26855125 |
79 | Abnormality of the salivary glands (HP:0010286) | 2.26594753 |
80 | Supernumerary ribs (HP:0005815) | 2.25896914 |
81 | Horizontal nystagmus (HP:0000666) | 2.24970498 |
82 | Myositis (HP:0100614) | 2.24955273 |
83 | Volvulus (HP:0002580) | 2.24830826 |
84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.23832187 |
85 | Mitochondrial inheritance (HP:0001427) | 2.23318433 |
86 | Vasculitis (HP:0002633) | 2.20869555 |
87 | Duplication of thumb phalanx (HP:0009942) | 2.20238635 |
88 | Attenuation of retinal blood vessels (HP:0007843) | 2.19442888 |
89 | Short humerus (HP:0005792) | 2.19253055 |
90 | Acute necrotizing encephalopathy (HP:0006965) | 2.18971941 |
91 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.16668176 |
92 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.16366092 |
93 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15467982 |
94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15467982 |
95 | Alveolar cell carcinoma (HP:0006519) | 2.14837348 |
96 | Abnormality of T cell number (HP:0011839) | 2.14034695 |
97 | Upper limb muscle weakness (HP:0003484) | 2.13816830 |
98 | Abnormality of renal resorption (HP:0011038) | 2.13098276 |
99 | Leukocytosis (HP:0001974) | 2.11858865 |
100 | Autoimmune hemolytic anemia (HP:0001890) | 2.10521514 |
101 | Microvesicular hepatic steatosis (HP:0001414) | 2.09091303 |
102 | Abnormality of the renal medulla (HP:0100957) | 2.08116506 |
103 | B lymphocytopenia (HP:0010976) | 2.07779429 |
104 | Cheilitis (HP:0100825) | 2.07146942 |
105 | Hypochromic anemia (HP:0001931) | 2.06886403 |
106 | Neutropenia (HP:0001875) | 2.05865333 |
107 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.05483258 |
108 | Preauricular pit (HP:0004467) | 2.05349492 |
109 | Periauricular skin pits (HP:0100277) | 2.05349492 |
110 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05236717 |
111 | Obstructive lung disease (HP:0006536) | 2.05236717 |
112 | Absent/shortened dynein arms (HP:0200106) | 2.04632541 |
113 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04632541 |
114 | Severe combined immunodeficiency (HP:0004430) | 2.03722462 |
115 | Abnormality of the lacrimal duct (HP:0011481) | 2.03099802 |
116 | Recurrent skin infections (HP:0001581) | 2.00869972 |
117 | Increased IgE level (HP:0003212) | 2.00267083 |
118 | Parakeratosis (HP:0001036) | 2.00076927 |
119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.99160539 |
120 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.98259916 |
121 | Increased CSF lactate (HP:0002490) | 1.98159623 |
122 | Trismus (HP:0000211) | 1.96780078 |
123 | Pulmonary infiltrates (HP:0002113) | 1.96553733 |
124 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96536624 |
125 | Abnormality of the preputium (HP:0100587) | 1.96405589 |
126 | Eosinophilia (HP:0001880) | 1.96207903 |
127 | Astrocytoma (HP:0009592) | 1.95626492 |
128 | Abnormality of the astrocytes (HP:0100707) | 1.95626492 |
129 | Hypothermia (HP:0002045) | 1.95371315 |
130 | Pustule (HP:0200039) | 1.95103951 |
131 | Dyschromatopsia (HP:0007641) | 1.94922326 |
132 | Large earlobe (HP:0009748) | 1.94267047 |
133 | Abnormality of the pleura (HP:0002103) | 1.93218567 |
134 | Congenital stationary night blindness (HP:0007642) | 1.93195406 |
135 | Progressive macrocephaly (HP:0004481) | 1.92488369 |
136 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.92441489 |
137 | Methylmalonic acidemia (HP:0002912) | 1.92194583 |
138 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91589473 |
139 | Granulocytopenia (HP:0001913) | 1.91552684 |
140 | T lymphocytopenia (HP:0005403) | 1.89744900 |
141 | Tongue fasciculations (HP:0001308) | 1.88821410 |
142 | Abnormality of eosinophils (HP:0001879) | 1.88728502 |
143 | Medial flaring of the eyebrow (HP:0010747) | 1.88339618 |
144 | Vertebral fusion (HP:0002948) | 1.87674520 |
145 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.87578022 |
146 | Abnormal ciliary motility (HP:0012262) | 1.87481147 |
147 | Pendular nystagmus (HP:0012043) | 1.86184303 |
148 | Increased IgM level (HP:0003496) | 1.84532513 |
149 | Hemoptysis (HP:0002105) | 1.84384375 |
150 | Abnormality of the renal cortex (HP:0011035) | 1.84152368 |
151 | Shawl scrotum (HP:0000049) | 1.83545341 |
152 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83270963 |
153 | Type I transferrin isoform profile (HP:0003642) | 1.83034042 |
154 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82852788 |
155 | Bile duct proliferation (HP:0001408) | 1.82223632 |
156 | Abnormal biliary tract physiology (HP:0012439) | 1.82223632 |
157 | Acute encephalopathy (HP:0006846) | 1.81995015 |
158 | Abnormality of dental color (HP:0011073) | 1.81527206 |
159 | Exertional dyspnea (HP:0002875) | 1.80421293 |
160 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79931254 |
161 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79931254 |
162 | Abnormality of chromosome segregation (HP:0002916) | 1.79646171 |
163 | Bronchitis (HP:0012387) | 1.79562430 |
164 | Abnormality of macular pigmentation (HP:0008002) | 1.78795488 |
165 | Stomatitis (HP:0010280) | 1.78029000 |
166 | Hyperventilation (HP:0002883) | 1.77602389 |
167 | Absent radius (HP:0003974) | 1.76830104 |
168 | Gangrene (HP:0100758) | 1.76461079 |
169 | Renal Fanconi syndrome (HP:0001994) | 1.75727362 |
170 | Abnormality of the nasolacrimal system (HP:0000614) | 1.75331683 |
171 | Small intestinal stenosis (HP:0012848) | 1.73785999 |
172 | Duodenal stenosis (HP:0100867) | 1.73785999 |
173 | Aplastic anemia (HP:0001915) | 1.73079801 |
174 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.72391558 |
175 | Abnormality of chromosome stability (HP:0003220) | 1.72209087 |
176 | Preauricular skin tag (HP:0000384) | 1.71302301 |
177 | Bone marrow hypocellularity (HP:0005528) | 1.69541800 |
178 | Retrobulbar optic neuritis (HP:0100654) | 1.68852786 |
179 | Optic neuritis (HP:0100653) | 1.68852786 |
180 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68549558 |
181 | Absent forearm bone (HP:0003953) | 1.68280081 |
182 | Aplasia involving forearm bones (HP:0009822) | 1.68280081 |
183 | Triphalangeal thumb (HP:0001199) | 1.66957076 |
184 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.66265564 |
185 | Villous atrophy (HP:0011473) | 1.66265564 |
186 | Asplenia (HP:0001746) | 1.65627850 |
187 | Abnormality of the prostate (HP:0008775) | 1.63997339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 6.96805403 |
2 | GRK5 | 3.96212152 |
3 | GRK6 | 3.68230182 |
4 | ADRBK2 | 3.30632775 |
5 | GRK1 | 3.05156640 |
6 | ERN1 | 2.77838115 |
7 | NUAK1 | 2.61430885 |
8 | MATK | 2.56486136 |
9 | CSF1R | 2.54620288 |
10 | GRK7 | 2.33293082 |
11 | STK10 | 2.22284896 |
12 | MAP4K2 | 2.02927974 |
13 | PLK4 | 1.99336012 |
14 | SRPK1 | 1.93336093 |
15 | MAPK7 | 1.82784562 |
16 | TGFBR2 | 1.81019587 |
17 | TYRO3 | 1.72756088 |
18 | STK24 | 1.72751823 |
19 | MAP3K14 | 1.72660887 |
20 | CDK7 | 1.69177145 |
21 | TTK | 1.62115036 |
22 | FRK | 1.55934592 |
23 | IKBKB | 1.54150554 |
24 | TXK | 1.47829540 |
25 | MST4 | 1.46871698 |
26 | TLK1 | 1.44480386 |
27 | BLK | 1.40678898 |
28 | AKT3 | 1.39618604 |
29 | WNK1 | 1.38638431 |
30 | BRD4 | 1.28524686 |
31 | ITK | 1.26036669 |
32 | MOS | 1.25634880 |
33 | SIK3 | 1.22699370 |
34 | EIF2AK2 | 1.21774883 |
35 | IRAK3 | 1.21573196 |
36 | VRK2 | 1.17676065 |
37 | CHUK | 1.17541615 |
38 | YES1 | 1.17349560 |
39 | TYK2 | 1.15867164 |
40 | CSK | 1.14480276 |
41 | SYK | 1.14098547 |
42 | EIF2AK3 | 1.13819501 |
43 | ZAK | 1.13722958 |
44 | MARK2 | 1.13478726 |
45 | HIPK2 | 1.12743056 |
46 | INSRR | 1.11726954 |
47 | ACVR1B | 1.10410203 |
48 | IRAK4 | 1.09039416 |
49 | STK16 | 1.06955574 |
50 | CHEK2 | 1.06629217 |
51 | ZAP70 | 1.01403353 |
52 | KIT | 0.99152716 |
53 | PIK3CG | 0.96960915 |
54 | MAPK13 | 0.96037165 |
55 | VRK1 | 0.92279869 |
56 | DYRK2 | 0.91896676 |
57 | SIK2 | 0.90939827 |
58 | BMPR1B | 0.89015392 |
59 | ADRBK1 | 0.88214641 |
60 | TESK2 | 0.88095813 |
61 | BUB1 | 0.87440105 |
62 | CAMK4 | 0.83019663 |
63 | FGFR3 | 0.82981487 |
64 | PLK1 | 0.81904482 |
65 | PBK | 0.79312292 |
66 | PIM1 | 0.79199038 |
67 | PRKG2 | 0.78755142 |
68 | FES | 0.77380143 |
69 | EPHB1 | 0.74594531 |
70 | MAP2K3 | 0.74269083 |
71 | MKNK2 | 0.71608720 |
72 | WNK3 | 0.70712395 |
73 | TNIK | 0.68206636 |
74 | EPHA2 | 0.67934529 |
75 | IRAK1 | 0.65013327 |
76 | TEC | 0.64706861 |
77 | STK4 | 0.64327476 |
78 | NME1 | 0.64213388 |
79 | CDK8 | 0.63629839 |
80 | NLK | 0.62519556 |
81 | LCK | 0.60355174 |
82 | EPHA3 | 0.60288824 |
83 | TAOK3 | 0.60018460 |
84 | MAPKAPK3 | 0.59523955 |
85 | DYRK3 | 0.59220665 |
86 | PLK2 | 0.58748064 |
87 | IRAK2 | 0.58481332 |
88 | JAK2 | 0.56172562 |
89 | PIM2 | 0.55559353 |
90 | * CHEK1 | 0.55128692 |
91 | CASK | 0.54494316 |
92 | CDC7 | 0.53721565 |
93 | PAK3 | 0.53058200 |
94 | JAK1 | 0.52690285 |
95 | MAP4K1 | 0.52247308 |
96 | NTRK1 | 0.51931450 |
97 | MKNK1 | 0.51357414 |
98 | MAP3K12 | 0.50573933 |
99 | PRKCI | 0.50085677 |
100 | PTK2B | 0.49338870 |
101 | PKN1 | 0.48516394 |
102 | PASK | 0.47835053 |
103 | BMPR2 | 0.47718785 |
104 | HCK | 0.47226530 |
105 | MAP3K3 | 0.46778666 |
106 | STK3 | 0.46149045 |
107 | CLK1 | 0.46125157 |
108 | CDK4 | 0.45615446 |
109 | GSK3A | 0.45499693 |
110 | MAP2K6 | 0.42076902 |
111 | PDK1 | 0.41666512 |
112 | OXSR1 | 0.41439214 |
113 | ALK | 0.41422548 |
114 | MAP2K2 | 0.41061314 |
115 | LYN | 0.40308638 |
116 | MAP3K13 | 0.39350527 |
117 | RIPK4 | 0.39218998 |
118 | IGF1R | 0.38302993 |
119 | PRKCD | 0.37802064 |
120 | ABL1 | 0.37659463 |
121 | MAP3K5 | 0.37548890 |
122 | INSR | 0.37089405 |
123 | CDK2 | 0.36538052 |
124 | PRKCQ | 0.36400493 |
125 | MAP3K10 | 0.36378717 |
126 | DYRK1A | 0.35980136 |
127 | AURKA | 0.35577889 |
128 | MAPK15 | 0.35284416 |
129 | TBK1 | 0.35161705 |
130 | PAK4 | 0.35043497 |
131 | ATM | 0.34939032 |
132 | JAK3 | 0.34688785 |
133 | ERBB3 | 0.34307070 |
134 | FER | 0.32363774 |
135 | CDK1 | 0.31753577 |
136 | IKBKE | 0.31587068 |
137 | MAP3K11 | 0.31010347 |
138 | BRSK2 | 0.30560082 |
139 | NEK6 | 0.29859793 |
140 | MARK3 | 0.29758630 |
141 | TNK2 | 0.28916191 |
142 | AKT2 | 0.27921701 |
143 | BTK | 0.27909421 |
144 | MAPK10 | 0.27802592 |
145 | MAPKAPK2 | 0.26904062 |
146 | FGR | 0.26564715 |
147 | TRPM7 | 0.24755150 |
148 | PLK3 | 0.23711566 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.48614997 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.37777837 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.97470627 |
4 | Proteasome_Homo sapiens_hsa03050 | 2.45824279 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20647991 |
6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.03467336 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02895410 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96585609 |
9 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.91867377 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87483203 |
11 | Homologous recombination_Homo sapiens_hsa03440 | 1.78160604 |
12 | RNA polymerase_Homo sapiens_hsa03020 | 1.75267112 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74975586 |
14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71515505 |
15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64046985 |
16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59829997 |
17 | Spliceosome_Homo sapiens_hsa03040 | 1.56798068 |
18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50939361 |
19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44262433 |
20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43945523 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40560023 |
22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37548348 |
23 | Mismatch repair_Homo sapiens_hsa03430 | 1.36655258 |
24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36125393 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31512390 |
26 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.28654139 |
27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28212782 |
28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27585468 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27301546 |
30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.26639914 |
31 | Measles_Homo sapiens_hsa05162 | 1.23549955 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23347625 |
33 | Allograft rejection_Homo sapiens_hsa05330 | 1.22725918 |
34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22117615 |
35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21984447 |
36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21112592 |
37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18161765 |
38 | DNA replication_Homo sapiens_hsa03030 | 1.17570521 |
39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17122710 |
40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16676436 |
41 | RNA transport_Homo sapiens_hsa03013 | 1.15054446 |
42 | Ribosome_Homo sapiens_hsa03010 | 1.14244353 |
43 | RNA degradation_Homo sapiens_hsa03018 | 1.14089272 |
44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12986675 |
45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11384876 |
46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05563827 |
47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03176895 |
48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02315980 |
49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02255494 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00742137 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99878834 |
52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97567996 |
53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97406873 |
54 | Cell cycle_Homo sapiens_hsa04110 | 0.97315943 |
55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96479265 |
56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95689885 |
57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94864221 |
58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94767017 |
59 | Phototransduction_Homo sapiens_hsa04744 | 0.92532142 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89577631 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87806401 |
62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87366238 |
63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86611029 |
64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85136449 |
65 | Base excision repair_Homo sapiens_hsa03410 | 0.84419679 |
66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83122985 |
67 | Malaria_Homo sapiens_hsa05144 | 0.79868645 |
68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78305596 |
69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77801217 |
70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77139212 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76786658 |
72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74467212 |
73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74441819 |
74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73394704 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73391143 |
76 | Apoptosis_Homo sapiens_hsa04210 | 0.73271056 |
77 | Legionellosis_Homo sapiens_hsa05134 | 0.72759466 |
78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72321049 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72242416 |
80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70082721 |
81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68286984 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.67296857 |
83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.66981199 |
84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66904805 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65600612 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64907307 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64759240 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63197527 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63057350 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61586374 |
91 | Asthma_Homo sapiens_hsa05310 | 0.61312373 |
92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60605854 |
93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59749166 |
94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59728902 |
95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59210482 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.58168033 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57345058 |
98 | Purine metabolism_Homo sapiens_hsa00230 | 0.56398883 |
99 | Shigellosis_Homo sapiens_hsa05131 | 0.56058224 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55697274 |
101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55446625 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54891892 |
103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54737038 |
104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53708787 |
105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53396609 |
106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52718564 |
107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51677980 |
108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51642623 |
109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51346580 |
110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50607731 |
111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49342135 |
112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49012665 |
113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48889324 |
114 | Protein export_Homo sapiens_hsa03060 | 0.48449465 |
115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48236519 |
116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47444029 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46609312 |
118 | Hepatitis C_Homo sapiens_hsa05160 | 0.45133510 |
119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45099280 |
120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44423199 |
121 | Tuberculosis_Homo sapiens_hsa05152 | 0.42831125 |
122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42819719 |
123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42571709 |
124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42220203 |
125 | Hepatitis B_Homo sapiens_hsa05161 | 0.40790909 |
126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40176364 |
127 | Phagosome_Homo sapiens_hsa04145 | 0.39716279 |
128 | Prostate cancer_Homo sapiens_hsa05215 | 0.39397957 |
129 | Viral myocarditis_Homo sapiens_hsa05416 | 0.30786283 |
130 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27443472 |
131 | Salmonella infection_Homo sapiens_hsa05132 | 0.26586899 |
132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25308578 |